SHANNON HOFFMAN: Open Payments
NPI 1689910713 · POTTSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,160 in 110 payments from 30 companies in 2025. Trend: 2023 $1,891 · 2024 $1,674 · 2025 $2,160
Food & beverage: $2,160
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $291 |
| PFIZER INC. | 14 | $258 |
| Novo Nordisk Inc | 12 | $225 |
| GlaxoSmithKline, LLC. | 9 | $188 |
| Lilly USA, LLC | 7 | $147 |
| Axsome Therapeutics, Inc. | 4 | $91 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| Lundbeck LLC | 3 | $79 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $67 |
| Exact Sciences Corporation | 3 | $61 |
Products named: VRAYLAR, TRELEGY ELLIPTA, REXULTI, JARDIANCE, PREVNAR 20, SHINGRIX, UBRELVY, SYNTHROID.
Industry payments across PA — which companies pay providers there.
